PDS Biotechnology (PDSB) Other Non-Current Assets (2014 - 2026)
PDS Biotechnology's (PDSB) quarterly Other Non-Current Assets came in at $2.0 million in Q4 2025, down 69.54% on a QoQ basis from $6.6 million in Q3 2025.
PDS Biotechnology (PDSB) Other Non-Current Assets (2014 - 2026) Analysis & Trends
PDS Biotechnology (PDSB) has 7 years of Other Non-Current Assets data on file, last reported at $2.0 million in Q4 2025.
- Quarterly Other Non-Current Assets changed N/A year-over-year to $2.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.0 million (changed N/A YoY) and the FY2025 annual result came in at $2.0 million, changed N/A from the prior year.
- Other Non-Current Assets slipped to $2.0 million in Q4 2025, from $6.6 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $6.6 million in Q2 2025 to a low of $2.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | PDS Biotechnology | 12.02 Mn | 12.02 Mn | - | 1.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.55 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Sep 30, 2025 | 6.55 Mn |
| Jun 30, 2025 | 6.55 Mn |
| Mar 31, 2025 | 4.27 Mn |
| Jun 30, 2019 | 145,470.00 |
| Mar 31, 2019 | 155,670.00 |
| Dec 31, 2018 | 12,800.00 |
| Sep 30, 2018 | 142,870.00 |
| Jun 30, 2018 | 142,870.00 |
| Mar 31, 2018 | 142,870.00 |
| Dec 31, 2017 | 142,870.00 |
| Sep 30, 2017 | 142,870.00 |
| Jun 30, 2017 | 142,870.00 |
| Mar 31, 2017 | 142,870.00 |
| Dec 31, 2016 | 142,870.00 |
| Sep 30, 2016 | 142,870.00 |
| Jun 30, 2016 | 142,870.00 |
| Mar 31, 2016 | 142,870.00 |
| Dec 31, 2015 | 55,161.00 |